Company Filing History:
Years Active: 1994-2011
Title: The Innovative Contributions of Patrick Chomez
Introduction
Patrick Chomez is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly through his work on tumor rejection antigens. With a total of 5 patents, Chomez has established himself as a key figure in the development of innovative therapeutic solutions.
Latest Patents
Among his latest patents are the isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-3. This invention relates to an isolated DNA sequence that codes for an antigen expressed by tumor cells, which is recognized by cytotoxic T cells, leading to the lysis of the tumor that expresses it. Additionally, he has developed nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor, which also involves an isolated DNA sequence with similar therapeutic implications.
Career Highlights
Patrick Chomez is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer immunology. His work has been instrumental in understanding how the immune system can be harnessed to target and destroy cancer cells.
Collaborations
Chomez has collaborated with esteemed colleagues such as Etienne De Plaen and Pierre Van Der Bruggen. These partnerships have further enriched his research and contributed to the advancement of cancer therapies.
Conclusion
Patrick Chomez's innovative work in the field of cancer research exemplifies the impact of dedicated inventors on medical science. His patents and collaborations highlight the importance of continued research in developing effective cancer treatments.